Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SACHI BIOWORKS, INC.
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2022-04-14 to 2025-04-13
Current total value of award: $2399976
Description: SBIR PHASE II REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS